CYRX

SEC source: 0001104659-22-055440 · tm2214402-5_4seq1.xml · nonDerivative · entry 2

ZECCHINI EDWARD J · CIK 0001587502 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,934

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: Restricted stock rights convert to common stock upon vesting on a one-for-one basis and have no expiration date.

SEC source: 0001104659-22-055441 · tm2214402-6_4seq1.xml · derivative · entry 3

BADDOUR LINDA · CIK 0001181151 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,708 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Restricted stock rights convert to common stock upon vesting on a one-for-one basis and have no expiration date.

F2 · derivative.expiration_date: Restricted stock rights convert to common stock upon vesting on a one-for-one basis and have no expiration date.

SEC source: 0001104659-22-055441 · tm2214402-6_4seq1.xml · nonDerivative · entry 2

BADDOUR LINDA · CIK 0001181151 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,363

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: Restricted stock rights convert to common stock upon vesting on a one-for-one basis and have no expiration date.

SEC source: 0001104659-22-055439 · tm2214402-4_4seq1.xml · derivative · entry 3

Mandalam Ramkumar · CIK 0001611439 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,708 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Restricted stock rights convert to common stock upon vesting on a one-for-one basis and have no expiration date.

F2 · derivative.expiration_date: Restricted stock rights convert to common stock upon vesting on a one-for-one basis and have no expiration date.

SEC source: 0001104659-22-055439 · tm2214402-4_4seq1.xml · nonDerivative · entry 2

Mandalam Ramkumar · CIK 0001611439 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,911

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: Restricted stock rights convert to common stock upon vesting on a one-for-one basis and have no expiration date.

SEC source: 0001104659-22-055438 · tm2214402-3_4seq1.xml · derivative · entry 3

Hariri Robert J · CIK 0001398815 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,708 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Restricted stock rights convert to common stock upon vesting on a one-for-one basis and have no expiration date.

F2 · derivative.expiration_date: Restricted stock rights convert to common stock upon vesting on a one-for-one basis and have no expiration date.

SEC source: 0001104659-22-055438 · tm2214402-3_4seq1.xml · nonDerivative · entry 2

Hariri Robert J · CIK 0001398815 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,911

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: Restricted stock rights convert to common stock upon vesting on a one-for-one basis and have no expiration date.

SEC source: 0001104659-22-055436 · tm2214402-2_4seq1.xml · derivative · entry 3

HANCOCK DANIEL M · CIK 0001764017 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,708 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Restricted stock rights convert to common stock upon vesting on a one-for-one basis and have no expiration date.

F2 · derivative.expiration_date: Restricted stock rights convert to common stock upon vesting on a one-for-one basis and have no expiration date.

SEC source: 0001104659-22-055436 · tm2214402-2_4seq1.xml · nonDerivative · entry 2

HANCOCK DANIEL M · CIK 0001764017 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,538

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: Restricted stock rights convert to common stock upon vesting on a one-for-one basis and have no expiration date.

SEC source: 0001104659-22-055435 · tm2214402-1_4seq1.xml · derivative · entry 4

BERMAN RICHARD J · CIK 0001111620 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,981

Underlying: Common Stock · 13,981 shares

Expires 2029-04-29

F3 · derivative.exercise_date: 1/12th of the options vest on the 30th of the month for twelve months beginning May 30, 2022.

SEC source: 0001104659-22-055435 · tm2214402-1_4seq1.xml · nonDerivative · entry 1

BERMAN RICHARD J · CIK 0001111620 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 107,203

F1 · security: Reflects grant of restricted stock rights that vest in full on April 29, 2023, and upon vesting automatically convert to shares of common stock on a one-for-one basis.

F1 · price: Reflects grant of restricted stock rights that vest in full on April 29, 2023, and upon vesting automatically convert to shares of common stock on a one-for-one basis.

SEC source: 0001104659-22-055440 · tm2214402-5_4seq1.xml · derivative · entry 4

ZECCHINI EDWARD J · CIK 0001587502 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,981

Underlying: Common Stock · 13,981 shares

Expires 2029-04-29

F3 · derivative.exercise_date: 1/12th of the options vest on the 30th of the month for twelve months beginning May 30, 2022.

SEC source: 0001104659-22-055440 · tm2214402-5_4seq1.xml · nonDerivative · entry 1

ZECCHINI EDWARD J · CIK 0001587502 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,226

F1 · security: Reflects grant of restricted stock rights that vest in full on April 29, 2023, and upon vesting automatically convert to shares of common stock on a one-for-one basis.

F1 · price: Reflects grant of restricted stock rights that vest in full on April 29, 2023, and upon vesting automatically convert to shares of common stock on a one-for-one basis.

SEC source: 0001104659-22-055441 · tm2214402-6_4seq1.xml · derivative · entry 4

BADDOUR LINDA · CIK 0001181151 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,891

Underlying: Common Stock · 13,981 shares

Expires 2029-04-29

F3 · derivative.exercise_date: 1/12th of the options vest on the 30th of the month for twelve months beginning May 30, 2022.

SEC source: 0001104659-22-055441 · tm2214402-6_4seq1.xml · nonDerivative · entry 1

BADDOUR LINDA · CIK 0001181151 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,655

F1 · security: Reflects grant of restricted stock rights that vest in full on April 29, 2023, and upon vesting automatically convert to shares of common stock on a one-for-one basis.

F1 · price: Reflects grant of restricted stock rights that vest in full on April 29, 2023, and upon vesting automatically convert to shares of common stock on a one-for-one basis.

SEC source: 0001104659-22-055439 · tm2214402-4_4seq1.xml · derivative · entry 4

Mandalam Ramkumar · CIK 0001611439 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,981

Underlying: Common Stock · 13,981 shares

Expires 2029-04-29

F3 · derivative.exercise_date: 1/12th of the options vest on the 30th of the month for twelve months beginning May 30, 2022.

SEC source: 0001104659-22-055439 · tm2214402-4_4seq1.xml · nonDerivative · entry 1

Mandalam Ramkumar · CIK 0001611439 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,203

F1 · security: Reflects grant of restricted stock rights that vest in full on April 29, 2023, and upon vesting automatically convert to shares of common stock on a one-for-one basis.

F1 · price: Reflects grant of restricted stock rights that vest in full on April 29, 2023, and upon vesting automatically convert to shares of common stock on a one-for-one basis.

SEC source: 0001104659-22-055438 · tm2214402-3_4seq1.xml · derivative · entry 4

Hariri Robert J · CIK 0001398815 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,981

Underlying: Common Stock · 13,981 shares

Expires 2029-04-29

F3 · derivative.exercise_date: 1/12th of the options vest on the 30th of the month for twelve months beginning May 30, 2022.

SEC source: 0001104659-22-055438 · tm2214402-3_4seq1.xml · nonDerivative · entry 1

Hariri Robert J · CIK 0001398815 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,203

F1 · security: Reflects grant of restricted stock rights that vest in full on April 29, 2023, and upon vesting automatically convert to shares of common stock on a one-for-one basis.

F1 · price: Reflects grant of restricted stock rights that vest in full on April 29, 2023, and upon vesting automatically convert to shares of common stock on a one-for-one basis.

SEC source: 0001104659-22-055436 · tm2214402-2_4seq1.xml · derivative · entry 4

HANCOCK DANIEL M · CIK 0001764017 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,981

Underlying: Common Stock · 13,981 shares

Expires 2029-04-29

F3 · derivative.exercise_date: 1/12th of the options vest on the 30th of the month for twelve months beginning May 30, 2022.

SEC source: 0001104659-22-055436 · tm2214402-2_4seq1.xml · nonDerivative · entry 1

HANCOCK DANIEL M · CIK 0001764017 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,830

F1 · security: Reflects grant of restricted stock rights that vest in full on April 29, 2023, and upon vesting automatically convert to shares of common stock on a one-for-one basis.

F1 · price: Reflects grant of restricted stock rights that vest in full on April 29, 2023, and upon vesting automatically convert to shares of common stock on a one-for-one basis.

SEC source: 0001104659-22-034626 · tm229493-1_4seq1.xml · derivative · entry 2

BADDOUR LINDA · CIK 0001181151 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,222

Underlying: Common Stock · 1,111 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The originally granted restricted stock rights vest in three equal annual installments beginning March 15, 2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 15, 2022.

F1 · kind: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock.

F2 · derivative.exercise_date: The originally granted restricted stock rights vest in three equal annual installments beginning March 15, 2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 15, 2022.

F2 · derivative.expiration_date: The originally granted restricted stock rights vest in three equal annual installments beginning March 15, 2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 15, 2022.

SEC source: 0001104659-22-034626 · tm229493-1_4seq1.xml · nonDerivative · entry 1

BADDOUR LINDA · CIK 0001181151 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,452

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock.

F1 · price: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock.

SEC source: 0001104659-22-034629 · tm229493-4_4seq1.xml · derivative · entry 2

Sawicki Mark W · CIK 0001848218 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,910

Underlying: Common Stock · 20,910 shares

Expires 2029-03-14

F2 · derivative.exercise_date: 1/48 of options vest on the 14th of each month for forty-eight months beginning 4/14/2022.

SEC source: 0001104659-22-034629 · tm229493-4_4seq1.xml · nonDerivative · entry 1

Sawicki Mark W · CIK 0001848218 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,841

F1 · security: Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning 3/14/2023.

F1 · price: Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning 3/14/2023.

SEC source: 0001104659-22-034628 · tm229493-3_4seq1.xml · derivative · entry 2

SHELTON JERRELL · CIK 0001283212 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,952

Underlying: Common Stock · 60,952 shares

Expires 2029-03-14

F2 · derivative.exercise_date: 1/48 of options vest on the 14th of each month for forty-eight months beginning 4/14/2022.

SEC source: 0001104659-22-034628 · tm229493-3_4seq1.xml · nonDerivative · entry 1

SHELTON JERRELL · CIK 0001283212 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 431,136

F1 · security: Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning 3/14/2023.

F1 · price: Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning 3/14/2023.

SEC source: 0001104659-22-034627 · tm229493-2_4seq1.xml · derivative · entry 2

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,910

Underlying: Common Stock · 20,910 shares

Expires 2029-03-14

F2 · derivative.exercise_date: 1/48 of options vest on the 14th of each month for forty-eight months beginning 4/14/2022.

SEC source: 0001104659-22-034627 · tm229493-2_4seq1.xml · nonDerivative · entry 1

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,256

F1 · security: Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning 3/14/2023.

F1 · price: Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning 3/14/2023.

SEC source: 0001104659-22-032999 · tm228984-3_4seq1.xml · derivative · entry 3

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,000

Underlying: Common Stock · 2,667 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The originally granted restricted stock rights vest in four equal annual installments beginning 3/9/2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2022.

F1 · kind: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock.

F3 · derivative.exercise_date: The originally granted restricted stock rights vest in four equal annual installments beginning 3/9/2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2022.

F3 · derivative.expiration_date: The originally granted restricted stock rights vest in four equal annual installments beginning 3/9/2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2022.

SEC source: 0001104659-22-032999 · tm228984-3_4seq1.xml · nonDerivative · entry 2

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,801

F2 · kind: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.

SEC source: 0001104659-22-032999 · tm228984-3_4seq1.xml · nonDerivative · entry 1

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,896

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock.

F1 · price: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock.

SEC source: 0001104659-22-032998 · tm228984-2_4seq1.xml · derivative · entry 3

SHELTON JERRELL · CIK 0001283212 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,750

Underlying: Common Stock · 8,250 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The originally granted restricted stock rights vest in four equal annual installments beginning 3/9/2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2022.

F1 · kind: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock.

F3 · derivative.exercise_date: The originally granted restricted stock rights vest in four equal annual installments beginning 3/9/2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2022.

F3 · derivative.expiration_date: The originally granted restricted stock rights vest in four equal annual installments beginning 3/9/2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2022.

SEC source: 0001104659-22-032998 · tm228984-2_4seq1.xml · nonDerivative · entry 2

SHELTON JERRELL · CIK 0001283212 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 404,044

F2 · kind: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights

SEC source: 0001104659-22-032998 · tm228984-2_4seq1.xml · nonDerivative · entry 1

SHELTON JERRELL · CIK 0001283212 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 407,342

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock.

F1 · price: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock.

SEC source: 0001104659-22-032997 · tm228984-1_4seq1.xml · derivative · entry 3

Sawicki Mark W · CIK 0001848218 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,000

Underlying: Common Stock · 2,667 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The originally granted restricted stock rights vest in four equal annual installments beginning 3/9/2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2022.

F1 · kind: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock.

F3 · derivative.exercise_date: The originally granted restricted stock rights vest in four equal annual installments beginning 3/9/2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2022.

F3 · derivative.expiration_date: The originally granted restricted stock rights vest in four equal annual installments beginning 3/9/2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2022.

SEC source: 0001104659-22-032997 · tm228984-1_4seq1.xml · nonDerivative · entry 2

Sawicki Mark W · CIK 0001848218 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,386

F2 · kind: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.

SEC source: 0001104659-22-032997 · tm228984-1_4seq1.xml · nonDerivative · entry 1

Sawicki Mark W · CIK 0001848218 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,796

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock.

F1 · price: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock.

SEC source: 0001104659-22-009896 · tm225040-1_4seq1.xml · derivative · entry 4

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,000 shares

Expires 2022-08-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Options vested in equal installments every 6 months for 48 months.

SEC source: 0001104659-22-009896 · tm225040-1_4seq1.xml · derivative · entry 3

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 47,812 shares

Expires 2026-05-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: 1/48 of the options vested on the 6th of each month for forty-eight months beginning on May 6, 2016.

SEC source: 0001104659-22-009896 · tm225040-1_4seq1.xml · nonDerivative · entry 2

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,229

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001104659-22-009896 · tm225040-1_4seq1.xml · nonDerivative · entry 1

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,229

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001104659-22-023895 · tm225040-2_5.xml · nonDerivative · entry 1

SHELTON JERRELL · CIK 0001283212 · Director · President, CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 399,092

SEC source: 0001104659-21-149797 · tm2135447-1_4.xml · derivative · entry 14

SHELTON JERRELL · CIK 0001283212 · Director · President, CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 286,377

Underlying: Common Stock · 287 shares

Expires 2023-06-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2021.

F11 · derivative.exercise_date: 1/24 of the options vested immediately and 1/46 of the remaining options vested on the 5th of each month for forty six months beginning on 7/5/2013 and ending on 5/5/2017.

SEC source: 0001104659-21-149797 · tm2135447-1_4.xml · nonDerivative · entry 11

SHELTON JERRELL · CIK 0001283212 · Director · President, CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 564,092

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2021.

SEC source: 0001104659-21-149797 · tm2135447-1_4.xml · nonDerivative · entry 10

SHELTON JERRELL · CIK 0001283212 · Director · President, CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 564,179

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2021.

F8 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.55 to $65.18, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001104659-21-149797 · tm2135447-1_4.xml · nonDerivative · entry 9

SHELTON JERRELL · CIK 0001283212 · Director · President, CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 564,379

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2021.

SEC source: 0001104659-21-149797 · tm2135447-1_4.xml · derivative · entry 13

SHELTON JERRELL · CIK 0001283212 · Director · President, CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 286,664

Underlying: Common Stock · 38,545 shares

Expires 2023-06-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2021.

F10 · derivative.exercise_date: 1/6 of the options vested on the 5th of each month for six months beginning on 12/5/2012 and ending on 5/5/2013.

SEC source: 0001104659-21-149797 · tm2135447-1_4.xml · derivative · entry 12

SHELTON JERRELL · CIK 0001283212 · Director · President, CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 26,418 shares

Expires 2022-11-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2021.

F9 · derivative.exercise_date: 1/12 of the options vested on the 22nd of each month for twelve months beginning on 11/22/2012 and ending on 10/22/2013.

SEC source: 0001104659-21-149797 · tm2135447-1_4.xml · nonDerivative · entry 8

SHELTON JERRELL · CIK 0001283212 · Director · President, CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 564,092

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2021.

F7 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.72 to $67.6950, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.